European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>Persistent’s €81 cash offer is now live, leaving a 3.7% gross spread. Binding shareholder arrangements and additional tender indications materially reduce acceptance risk.</li>
<li>Regulatory approvals remain the principal timetable variable rather than an obvious source of break risk. Persistent targets completion by end-Q1 2027, with financing fully committed.</li>
<li>We raise completion probability from 80% to 92% and estimate €79.72 probability-weighted value. Interloper optionality has diminished given the contractual protections around Persistent’s offer.</li>
</ul>


Persistent’s €81 cash offer is now live, leaving a 3.7% gross spread. Binding shareholder arrangements and additional tender indications materially reduce acceptance risk.
Regulatory approvals remain the principal timetable variable rather than an obvious source of break risk. Persistent targets completion by end-Q1 2027, with financing fully committed.
We raise completion probability from 80% to 92% and estimate €79.72 probability-weighted value. Interloper optionality has diminished given the contractual protections around Persistent’s offer.


Persistent Systems / Nagarro: Offer Live, 3.7% Spread with Acceptance Risk Reduced

External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Thematic (Sector/Industry)

<ul><li>Nestle India: Nestle’s 1QCY23 earnings surprised positively, led by strong revenue performance. However, the margin saw a marginal miss</li><li>Domestic revenue grew 21% YoY while exports grew by 25%</li><li>The growth was led by a healthy balance of pricing, volume and mix (around mid-single-digit volume growth)</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Nestle India: Nestle’s 1QCY23 earnings surprised positively, led by strong revenue performance. However, the margin saw a marginal missDomestic revenue grew 21% YoY while exports grew by 25%The growth was led by a healthy balance of pricing, volume and mix (around mid-single-digit volume growth)Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HSIE Results Daily: Nestle India, Bajaj Auto, AU Small Finance Bank, Persistent Systems

<ul><li>Nestle India: Nestle’s 1QCY23 earnings surprised positively, led by strong revenue performance</li><li>However, the margin saw a marginal miss. Domestic revenue grew 21% YoY while exports grew by 25%</li><li>The growth was led by a healthy balance of pricing, volume and mix (around mid-single-digit volume growth)</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Nestle India: Nestle’s 1QCY23 earnings surprised positively, led by strong revenue performanceHowever, the margin saw a marginal miss. Domestic revenue grew 21% YoY while exports grew by 25%The growth was led by a healthy balance of pricing, volume and mix (around mid-single-digit volume growth)Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HSIE Results Daily - Nestle India, Bajaj Auto, AU Small Finance Bank, Persistent Systems

APAC IPOs & Placements, Aequitas Research

Akshat Shah

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Dr Agarwal's Health Care Ltd / Equity Capital Markets

Dr Agarwal's Health Care Ltd (8140044Z IN)

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dr-agarwal-s-health-care-ltd" target="_blank" data-smartkarma-citation="entities:43984:1" rel="noopener">Dr Agarwal's Health Care Ltd (8140044Z IN)</a> raised around US$350m in its India IPO in Jan 2025. The lockup on its pre-IPO investors is set to expire soon.</li>
<li>Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.</li>
<li>In this note, we will talk about the lockup dynamics and possible placement.</li>
</ul>



Dr Agarwal's Health Care Ltd (8140044Z IN) raised around US$350m in its India IPO in Jan 2025. The lockup on its pre-IPO investors is set to expire soon.
Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.
In this note, we will talk about the lockup dynamics and possible placement.


Dr Agarwal’s Health Care IPO Lockup - US$725m Lockup Release; PE Investors May Look to Cash Out

<ul><li>IT sector is expected to post a soft Q4 on increased macro uncertainty</li><li>We expect tier-1 IT to post growth in the range of -2% to +1% QoQ and mid-tier IT to post growth in the range of -1.4% to 2.6% QoQ CC organic</li><li>Deal flow is expected to be strongly supported by increased cost optimisation deals and vendor consolidation by enterprise clients</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

IT sector is expected to post a soft Q4 on increased macro uncertaintyWe expect tier-1 IT to post growth in the range of -2% to +1% QoQ and mid-tier IT to post growth in the range of -1.4% to 2.6% QoQ CC organicDeal flow is expected to be strongly supported by increased cost optimisation deals and vendor consolidation by enterprise clientsContent is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

IT (Q4FY23E Results Preview): Soft quarter; outlook holds the key

India

Persistent Systems is a global digital engineering and enterprise modernization company. It provides information technology and software engineering services, including software product engineering, cloud services, and data-driven solutions to clients across industries like banking, healthcare, and technology. The company was founded in 1990 and is headquartered in Pune, India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Persistent Systems (PSYS IN)

Persistent Systems / Nagarro: Offer Live, 3.7% Spread with Acceptance Risk Reduced

Persistent’s €81 offer is now live. The spread remains attractive as acceptance risk falls, while regulatory timing rather than deal completion is...

Jesus Rodriguez Aguilar

HSIE Results Daily: Nestle India, Bajaj Auto, AU Small Finance Bank, Persistent Systems

Nestle India: Nestle’s 1QCY23 earnings surprised positively, led by strong revenue performance. However, the margin saw a marginal miss

HDFC Securities

HSIE Results Daily - Nestle India, Bajaj Auto, AU Small Finance Bank, Persistent Systems

Nestle India: Nestle’s 1QCY23 earnings surprised positively, led by strong revenue performance. However, the margin saw a marginal miss. Domestic...

HDFC Securities

Dr Agarwal’s Health Care IPO Lockup - US$725m Lockup Release; PE Investors May Look to Cash Out

TPG and Temasek are selling part of their stakes , around 11% of Dr Agarwal Health Care's existing share capital, to raise around US$183m, at a...

Akshat Shah

IT (Q4FY23E Results Preview): Soft quarter; outlook holds the key

We expect tier-1 IT to post growth in the range of -2% to +1% QoQ and mid-tier IT to post growth in the range of -1.4% to 2.6% QoQ CC organic

HDFC Securities

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)